Screening programme to be extended to Wakefield
Hundreds of people in Wakefield and across the region will [...]
Cabozantinib most promising for refractory metastatic kidney cancer
In a European study of second-line treatments for metastatic kidney [...]
Combination therapy shows promise for hereditary papillary kidney cancer
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated papillary RCC is [...]
Kidney cancer becoming more common in younger people?
A study conducted by American researchers has identified an increase [...]
UK regulators approve injectable form of nivolumab for solid tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
Europe has approved subcutaneous nivolumab for solid tumours
The Committee for Medicinal Products for Human Use (CHMP) of [...]
A urine test to detect the return of kidney cancer
A study has shown that a simple urine test could [...]
Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
